NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

ECMC

Experimental Cancer Medicine Centres (ECMC) researchers are world-leading scientists and clinicians who drive the discovery, development and testing of new treatments to combat cancer. The funding supports over 200 staff involved in early phase trials and translational research.

P.R. Oct. 28, 2015.

ECMC funding supports the Cell and Gene Therapy (CGT) component of the CTU at the NIHR Biomedical Research Centre. Professor Farzin Farzaneh leads the CGT arm of the project that plays a key role in facilitating the delivery of DCVax-L to patients in the UK.

https://www.ecmcnetwork.org.uk/news/announcement/kings-college-hospital-lead-dcvas-l-study